Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,994 | 8 | 62.4% |
| Unspecified | $6,390 | 2 | 33.2% |
| Travel and Lodging | $779.00 | 2 | 4.1% |
| Food and Beverage | $54.58 | 2 | 0.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $10,829 | 5 | $0 (2017) |
| Vertex Pharmaceuticals Incorporated | $6,000 | 4 | $0 (2021) |
| AstraZeneca UK Limited | $2,334 | 3 | $0 (2024) |
| Relypsa, Inc. | $40.00 | 1 | $0 (2017) |
| Novo Nordisk Inc | $14.58 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,556 | 2 | AstraZeneca UK Limited ($1,556) |
| 2023 | $792.58 | 2 | AstraZeneca UK Limited ($778.00) |
| 2021 | $3,120 | 2 | Vertex Pharmaceuticals Incorporated ($3,120) |
| 2020 | $2,880 | 2 | VERTEX PHARMACEUTICALS INCORPORATED ($2,880) |
| 2017 | $10,869 | 6 | Novartis Pharmaceuticals Corporation ($10,829) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $778.00 | General |
| 06/13/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $778.00 | General |
| 12/14/2023 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $778.00 | General |
| 06/26/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Obesity | ||||||
| 10/20/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| 05/05/2021 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| 12/02/2020 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| 08/05/2020 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| 11/21/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | CFZ533 (Biological) | — | In-kind items and services | $4,712.50 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT | ||||||
| 10/07/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: Hyperkalemia | ||||||
| 04/29/2017 | NOVARTIS PHARMACEUTICALS CORPORATION | — | — | In-kind items and services | $1,677.00 | Research |
| Study: RESEARCH RELATED PUBLICATION SUPPORT | ||||||
| 02/21/2017 | Novartis Pharmaceuticals Corporation | FCR001 (Biological) | Consulting Fee | Cash or cash equivalent | $3,660.00 | General |
| 01/13/2017 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $375.00 | General |
| 01/12/2017 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $404.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $6,390 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 18 | 20 | $3,047 | $1,523 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 20 | $3,047 | $1,523 | 50.0% |
About Akinlolu Ojo, MBBS, PHD, MPH
Akinlolu Ojo, MBBS, PHD, MPH is a Internal Medicine healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649352550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Akinlolu Ojo, MBBS, PHD, MPH has received a total of $19,217 in payments from pharmaceutical and medical device companies, with $1,556 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($11,994).
As a Medicare-enrolled provider, Ojo has provided services to 18 Medicare beneficiaries, totaling 20 services with total Medicare billing of $1,523. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Ann Arbor, MI
- Active Since 10/19/2006
- Last Updated 03/27/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1649352550
Products in Payments
- CFZ533 (Biological) $4,713
- FCR001 (Biological) $3,660
- Veltassa (Drug) $40.00
- Wegovy (Drug) $14.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Ann Arbor
Dr. Marschall Runge, Md, MD
Internal Medicine — Payments: $2.3M
Terry Smith, M.d, M.D
Internal Medicine — Payments: $2.1M
Harry Erba, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Dinesh Khanna, M.d, M.D
Internal Medicine — Payments: $1.2M
Alexander Yevzlin, Md, MD
Internal Medicine — Payments: $1.2M
Vallerie Mclaughlin, Md, MD
Internal Medicine — Payments: $1.1M